BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30291167)

  • 1. Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells.
    Li Y; Guan X; Liu W; Chen HL; Truscott J; Beyatli S; Metwali A; Weiner GJ; Zavazava N; Blumberg RS; Urban JF; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2018 Nov; 201(10):2910-2922. PubMed ID: 30291167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
    Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
    Pillai AB; George TI; Dutt S; Strober S
    Blood; 2009 Apr; 113(18):4458-67. PubMed ID: 19221040
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hang L; Kumar S; Blum AM; Urban JF; Fantini MC; Weinstock JV
    J Immunol; 2019 Apr; 202(8):2473-2481. PubMed ID: 30850474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway.
    Grainger JR; Smith KA; Hewitson JP; McSorley HJ; Harcus Y; Filbey KJ; Finney CA; Greenwood EJ; Knox DP; Wilson MS; Belkaid Y; Rudensky AY; Maizels RM
    J Exp Med; 2010 Oct; 207(11):2331-41. PubMed ID: 20876311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.
    Tawara I; Shlomchik WD; Jones A; Zou W; Nieves E; Liu C; Toubai T; Duran-Struuck R; Sun Y; Clouthier SG; Evers R; Lowler KP; Levy RB; Reddy P
    J Immunol; 2010 Oct; 185(7):3866-72. PubMed ID: 20810991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.
    Kim BS; Nishikii H; Baker J; Pierini A; Schneidawind D; Pan Y; Beilhack A; Park CG; Negrin RS
    Blood; 2015 Jul; 126(4):546-57. PubMed ID: 26063163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 controls susceptibility to helminth infection by impeding Th2 responsiveness and altering the Treg phenotype in vivo.
    Smith KA; Maizels RM
    Eur J Immunol; 2014 Jan; 44(1):150-61. PubMed ID: 24185641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
    Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
    Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
    Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.
    Shin HJ; Baker J; Leveson-Gower DB; Smith AT; Sega EI; Negrin RS
    Blood; 2011 Aug; 118(8):2342-50. PubMed ID: 21734238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation.
    Ince MN; Elliott DE; Setiawan T; Metwali A; Blum A; Chen HL; Urban JF; Flavell RA; Weinstock JV
    Eur J Immunol; 2009 Jul; 39(7):1870-8. PubMed ID: 19544487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation.
    Xie Y; Wu M; Song R; Ma J; Shi Y; Qin W; Jin Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Sep; 41(9):781-91. PubMed ID: 19727527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion and activation of CD4(+)CD25(+) regulatory T cells in Heligmosomoides polygyrus infection.
    Finney CA; Taylor MD; Wilson MS; Maizels RM
    Eur J Immunol; 2007 Jul; 37(7):1874-86. PubMed ID: 17563918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of allergic airway inflammation by helminth-induced regulatory T cells.
    Wilson MS; Taylor MD; Balic A; Finney CA; Lamb JR; Maizels RM
    J Exp Med; 2005 Nov; 202(9):1199-212. PubMed ID: 16275759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice.
    Chen C; Cao J; Zeng L; Li Y; Wang D; Xu K
    Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Stat1 in donor CD4⁺ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice.
    Ma H; Lu C; Ziegler J; Liu A; Sepulveda A; Okada H; Lentzsch S; Mapara MY
    J Clin Invest; 2011 Jul; 121(7):2554-69. PubMed ID: 21670504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice.
    Semple K; Yu Y; Wang D; Anasetti C; Yu XZ
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):309-18. PubMed ID: 21224010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths.
    Smith KA; Filbey KJ; Reynolds LA; Hewitson JP; Harcus Y; Boon L; Sparwasser T; Hämmerling G; Maizels RM
    Mucosal Immunol; 2016 Mar; 9(2):428-43. PubMed ID: 26286232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.